Document is current
Any future updates will be listed below
-
Authors
Kalantar-Zadeh, Kamyar https://orcid.org/0000-0002-8666-0725
Li, Philip Kam-Tao https://orcid.org/0000-0001-9879-8388
Tantisattamo, Ekamol https://orcid.org/0000-0003-0883-6892
Kumaraswami, Latha
Liakopoulos, Vassilios https://orcid.org/0000-0002-7564-2724
Lui, Siu-Fai https://orcid.org/0000-0003-0800-8982
Ulasi, Ifeoma https://orcid.org/0000-0001-7783-3025
Andreoli, Sharon
Balducci, Alessandro https://orcid.org/0000-0002-7432-1494
Dupuis, Sophie
Harris, Tess https://orcid.org/0000-0003-3659-7438
Hradsky, Anne
Knight, Richard
Kumar, Sajay
Ng, Maggie
Poidevin, Alice
Saadi, Gamal https://orcid.org/0000-0002-6280-1685
Tong, Allison https://orcid.org/0000-0001-8973-9538
,
Li, Philip Kam Tao
Kalantar-Zadeh, Kamyar
Andreoli, Sharon
Balducci, Alessandro
Dupuis, Sophie
Kumaraswami, Latha
Liakopoulos, Vassilios
Lui, Siu-Fai
Saadi, Gamal
Ulasi, Ifeoma
- License Information
-
More Information
Article History
Received: 24 January 2021
Accepted: 1 March 2021
First Online: 15 March 2021
Declarations
:
: K.K.-Z. reports honoraria from Abbott, Abbvie, ACI Clinical, Akebia, Alexion, Amgen, Ardelyx, Astra-Zeneca, Aveo, BBraun, Cara Therapeutics, Chugai, Cytokinetics, Daiichi, DaVita, Fresenius, Genentech, Haymarket Media, Hospira, Kabi, Keryx, Kissei, Novartis, Pfizer, Regulus, Relypsa, Resverlogix, Dr Schaer, Sandoz, Sanofi, Shire, Vifor, UpToDate, and ZS-Pharma. P.K.T.L. reports personal fees from Fibrogen and Astra-Zeneca. G.S. reports personal fees from Multicare, Novartis, Sandoz, and Astra-Zeneca. V.L. reports nonfinancial support from Genesis Pharma. ET, LK, SL, IU, SA, AB, SD, TH, AH, RK, SK, MN, AP, and AT have declared that no conflict of interest exists.
: This article does not contain any studies with human participants performed by any of the authors.
: Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
